文献速递母胎医学产科

胎儿先天性淋巴管异常的遗传学研究

Investigation into the genetics of fetal congenital lymphatic anomalies.
PubMed 文献 · Prenat Diagn · 2023-04-03

本研究对71例标准检查后仍未确诊的胎儿水肿病例进行全外显子组测序(WES),并按美国医学遗传学与基因组学学会标准分析淋巴管异常相关基因。结果在7%(5/71)病例中检出致病性或可能致病性变异,在45%(32/71)病例中检出意义不明确的变异(VOUS),合计51%病例检出淋巴管异常基因变异,支持对特发性胎儿水肿及液体积聚病例行WES和扩展性水肿基因组检测。

要点

  • 标准检查未确诊的胎儿水肿病例中,WES检出淋巴管异常基因致病或可能致病变异者为7%(5/71)。
  • 意义不明确的变异(VOUS)检出率为45%(32/71),涉及CELSR1、EPHB4、TIE1、PIEZO1、ITGA9及RASopathy相关基因等。
  • 临床显著胎儿水肿(CSFE)病例结局不良,包括早产、死亡和母亲子痫前期。

核心结论

  • WES在51%的胎儿水肿病例中检出淋巴管异常基因的致病性、可能致病性变异或VOUS,支持对特发性胎儿水肿及液体积聚病例行WES和扩展性水肿基因组检测。

研究设计与样本

  • 对71例标准检查后仍未确诊的胎儿水肿病例的全外显子组测序(WES)数据,按美国医学遗传学与基因组学学会标准进行淋巴管异常基因的靶向变异分析。
  • 比较临床显著胎儿水肿(CSFE)与孤立性胎儿水肿两个亚队列的人口学数据。

主要发现

  • 致病性和可能致病性变异见于7%(5/71)病例,包括RASopathy基因RASA1、SOS1、PTPN11变异及一个新发PIEZO1变异。
  • 意义不明确的变异(VOUS)见于45%(32/71)病例。
  • CSFE病例的VOUS见于CELSR1、EPHB4、TIE1、PIEZO1、ITGA9、RASopathy基因SOS1、SOS2和RAF1。
  • CSFE病例结局不良,包括早产、死亡和母亲子痫前期。

临床怎么用

  • 作者认为,对特发性胎儿水肿和液体积聚病例应支持行WES和扩展性水肿基因组检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Congenital lymphatic anomalies (LAs) arise due to defects in lymphatic development and often present in utero as pleural effusion, chylothorax, nuchal and soft tissue edema, ascites, or hydrops. Many LAs are caused by single nucleotide variants, which are not detected on routine prenatal testing. METHODS: Demographic data were compared between two subcohorts, those with clinically significant fetal edema (CSFE) and isolated fetal edema. A targeted variant analysis of LA genes was performed using American College of Medical Genetics criteria on whole exome sequencing (WES) data generated for 71 fetal edema cases who remained undiagnosed after standard workup. RESULTS: CSFE cases had poor outcomes, including preterm delivery, demise, and maternal preeclampsia. Pathogenic and likely pathogenic variants were identified in 7% (5/71) of cases, including variants in RASopathy genes, RASA1, SOS1, PTPN11, and a novel PIEZO1 variant. Variants of uncertain significance (VOUS) were identified in 45% (32/71) of cases. In CSFEs, VOUS were found in CELSR1, EPHB4, TIE1, PIEZO1, ITGA9, RASopathy genes, SOS1, SOS2, and RAF1. CONCLUSIONS: WES identified pathogenic and likely pathogenic variants and VOUS in LA genes in 51% of fetal edema cases, supporting WES and expanded hydrops panels in cases of idiopathic fetal hydrops and fluid collections.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Rogerson D, Alkelai A, Giordano J, et al. Investigation into the genetics of fetal congenital lymphatic anomalies. Prenat Diagn. 2023. PMID: 36959127. doi:10.1002/pd.6345

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。